Efficacy of Injectable Collagenase in the Treatment of Dupuytren's Contracture in Comparison to Partial Fasciectomy

Shaw Jr. R.B., Chong A.K., Zhang A., Hentz V.R. and
Chang J.: Dupuytren's disease: History, diagnosis, and
treatment. J. Plastic Reconstructive Surgery, 120: 44e-
54e, 2007.
2- Townley W., Baker R., Sheppard N. and Grobbelaar A.:
Dupuytren's contracture unfolded. J. B.M.J.: British
Medical Journal, 332: 397, 2006.
3- Watt A.J., Curtin C.M. and Hentz V.R.: Collagenase
injection as nonsurgical treatment of Dupuytren's disease:
8-year follow-up. J. The Journal of hand surgery, 35: 534-
539. e531, 2010.
4- Gelbard M.K., James K., Riach P. and Dorey F.: Collagenase
versus placebo in the treatment of Peyronie's
disease: A double-blind study. J. The Journal of Urology,
149: 56-58, 1993.
5- Nydick J.A., Olliff B.W., Garcia M.J., Hess A.V. and
Stone J.D.: A comparison of percutaneous needle fasciotomy
and collagenase injection for Dupuytren disease. J.
The Journal of Hand Surgery, 38: 2377-2380, 2013.
6- Peimer C.A., Blazar P., Coleman S., Kaplan F.T.D., Smith
T. and Lindau T.: Dupuytren contracture recurrence following
treatment with collagenase clostridium histolyticum
(CORDLESS [Collagenase Option for Reduction of Dupuytren
Long-Term Evaluation of Safety Study]): 5-year
194 Vol. 43, No. 2 / Efficacy of Injectable Collagenase in the Treatment of Dupuytren's Contracture
data. J. The Journal of Hand Surgery, 40: 1597-1605,
2015.
7- Skirven T.M., Bachoura A., Jacoby S.M., Culp R.W. and
Osterman A.L.: The effect of a therapy protocol for
increasing correction of severely contracted proximal
interphalangeal joints caused by Dupuytren disease and
treated with collagenase injection. J. The Journal of Hand
Surgery, 38: 684-689, 2013.
8- Coleman S., Gilpin D., Kaplan F.T.D., et al.: Efficacy and
safety of concurrent collagenase clostridium histolyticum
injections for multiple Dupuytren contractures. J. The
Journal of Hand Surgery, 39: 57-64, 2014.
9- Hovius S.E., Kan H.J., Smit X., Selles R.W., Cardoso E.
and Khouri R.K.: Extensive percutaneous aponeurotomy
and lipografting: A new treatment for Dupuytren disease.
J. Plastic Reconstructive Surgery, 128: 221-228, 2011.
10- Van Rijssen A.L., Ter Linden H. and Werker P.M.: Fiveyear
results of a randomized clinical trial on treatment in
Dupuytren's disease: Percutaneous needle fasciotomy
versus limited fasciectomy. J. Plastic Reconstructive
Surgery, 129: 469-477, 2012.
11- Scherman P., Jenmalm P. and Dahlin L.: One-year results
of needle fasciotomy and collagenase injection in treatment
of Dupuytren's contracture: A two-centre prospective
randomized clinical trial. J. Journal of Hand Surgery, 41:
577-582, 2016.
12- Desai S.S. and Hentz V.R.: Collagenase clostridium
histolyticum for Dupuytren's contracture. J. Expert Opinion
on Biological Therapy, 10: 1395-1404, 2010.
13- Warwick D., Arner M., Pajardi G., et al.: Collagenase
Clostridium histolyticum in patients with Dupuytren's
contracture: Results from POINT X, an open-label study
of clinical and patient-reported outcomes. J. Journal of
Hand Surgery, 40: 124-132, 2015.
14- Zhou, C., Hovius, S.E., Slijper, H.P., et al. Collagenase
clostridium histolyticum versus limited fasciectomy for
Dupuytren's contracture: outcomes from a multicenter
propensity score matched study. J. Plastic Reconstructive
Surgery, 136: 87-97, 2015.
15- Starkweather K.D., Lattuga S., Hurst L.C., et al.: Collagenase
in the treatment of Dupuytren's disease: AN in
vitro study. J. The Journal of Hand Surgery, 21: 490-495,
1996.
16- Badalamente M.A., Hurst L.C. and Hentz V.R.: Collagen
as a clinical target: Nonoperative treatment of Dupuytren's
disease. J. The Journal of Hand Surgery, 27: 788-798,
2002.
17- Peimer C., Wilbrand S., Gerber R., Chapman D. and
Szczypa P.: Safety and tolerability of collagenase Clostridium
histolyticum and fasciectomy for Dupuytren's contracture.
J. Journal of Hand Surgery, 40: 141-9, 2015.
18- Chen N.C., Shauver M.J. and Chung K.C.: Costeffectiveness
of open partial fasciectomy, needle aponeurotomy,
and collagenase injection for Dupuytren contracture.
J. The Journal of Hand Surgery, 36: 1826-1834.
e1832, 2011.
19- Atroshi I., Strandberg E., Lauritzson A., Ahlgren E. and
Waldén M.: Costs for collagenase injections compared
with fasciectomy in the treatment of Dupuytren's contracEgypt,
J. Plast. Reconstr. Surg., July 2019 195
ture: A retrospective cohort study. J. B.M.J. open, 4:
e004166, 2014.
20- Cerveró R.S., Ferrando N.F. and Jornet J.P.: Use of
resources and costs associated with the treatment of
Dupuytren's contracture at an orthopedics and traumatology
surgery department in Denia (Spain): Collagenase
clostridium hystolyticum versus subtotal fasciectomy. J.
B.M.C. Musculoskeletal Disorders, 14: 293, 2013.
21- Peimer C.A., Blazar P., Coleman S., et al.: Dupuytren
contracture recurrence following treatment with collagenase
clostridium histolyticum (CORDLESS study): 3-
year data. J. The Journal of Hand Surgery, 38: 12-22,
2013.
22- Lipshultz L.I., Goldstein I., Seftel A.D., et al.: Clinical
efficacy of collagenase Clostridium histolyticum in the
treatment of Peyronie's disease by subgroup: Results from
two large, double-blind, randomized, placebo-controlled,
phase III studies, 116: 650-656, 2015.
23- Povlsen B. and Povlsen S.D.J.H.S.: What is the better
treatment for single digit dupuytren's contracture: Surgical
release or collagenase clostridium histolyticum (Xiapex)
injection? 19: 389-392, 2014.